135 related articles for article (PubMed ID: 22826900)
1. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
Marum L
Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
[No Abstract] [Full Text] [Related]
2. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
McBride D
ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
[No Abstract] [Full Text] [Related]
3. A gene expression database for the molecular pharmacology of cancer.
Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
[TBL] [Abstract][Full Text] [Related]
4. The era of cancer discovery.
Cantley LC; Baselga J
Cancer Discov; 2011 Jun; 1(1):1. PubMed ID: 22586302
[No Abstract] [Full Text] [Related]
5. Chemical data mining of the NCI human tumor cell line database.
Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
[TBL] [Abstract][Full Text] [Related]
6. Curing "incurable" cancer.
Watson JD
Cancer Discov; 2011 Nov; 1(6):477-80. PubMed ID: 22586652
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug efficacy for cancer treatment based on comparative analysis of chemosensitivity and gene expression data.
Wan P; Li Q; Larsen JE; Eklund AC; Parlesak A; Rigina O; Nielsen SJ; Björkling F; Jónsdóttir SÓ
Bioorg Med Chem; 2012 Jan; 20(1):167-76. PubMed ID: 22154557
[TBL] [Abstract][Full Text] [Related]
8. Tackling transcription factors: challenges in antitumor therapy.
Grivas PD; Kiaris H; Papavassiliou AG
Trends Mol Med; 2011 Oct; 17(10):537-8. PubMed ID: 21775208
[No Abstract] [Full Text] [Related]
9. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
[TBL] [Abstract][Full Text] [Related]
10. Multiple effects of bioflavonoids on gene regulation, cell proliferation and apoptosis: natural compounds move into the lime light of cancer research.
Strissel PL; Strick R
Leuk Res; 2005 Aug; 29(8):859-61. PubMed ID: 15967500
[No Abstract] [Full Text] [Related]
11. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
Huang R; Wallqvist A; Thanki N; Covell DG
Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
13. Blocking cancer with RNA interference moves toward the clinic.
Hede K
J Natl Cancer Inst; 2005 May; 97(9):626-8. PubMed ID: 15870429
[No Abstract] [Full Text] [Related]
14. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
15. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
16. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
17. Novartis Compiles Mouse Avatar "Encyclopedia".
Poh A
Cancer Discov; 2016 Jan; 6(1):5-6. PubMed ID: 26621761
[TBL] [Abstract][Full Text] [Related]
18. Systems biology makes it personal.
Brynildsen MP; Collins JJ
Mol Cell; 2009 Apr; 34(2):137-8. PubMed ID: 19394290
[TBL] [Abstract][Full Text] [Related]
19. Cancer pharmacogenetics.
Marsh S
Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
